Stockscreener 앱 받기
3.46
2.26%
-0.08
전일 마감가:
$3.54
열려 있는:
$3.54
하루 거래량:
2.01M
Relative Volume:
1.81
시가총액:
$256.95M
수익:
$6.96M
순이익/손실:
$-46.51M
주가수익비율:
-20.16
EPS:
-0.1716
순현금흐름:
$-37.99M
1주 성능:
+2.98%
1개월 성능:
-11.73%
6개월 성능:
+36.76%
1년 성능:
-77.59%
1일 변동 폭
$3.44
$3.85
1주일 범위
$3.20
$3.85
52주 변동 폭
$1.60
$16.31
Perspective Therapeutics Inc Stock (CATX) Company Profile
명칭
Perspective Therapeutics Inc
전화
509-375-1202
주소
350 Hills Street, Suite 106, Richland
CATX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CATX
Perspective Therapeutics Inc
|
3.46 | 262.89M | 6.96M | -46.51M | -37.99M | -0.1716 |
|
ABT
Abbott Laboratories
|
132.94 | 231.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.22 | 158.98B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
392.31 | 150.76B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.90 | 119.10B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.94 | 47.53B | 5.69B | 1.41B | 577.90M | 6.95 |
Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-13 | 개시 | H.C. Wainwright | Buy |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2024-11-25 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-10-01 | 개시 | Wedbush | Outperform |
| 2024-09-25 | 개시 | Truist | Buy |
| 2024-07-25 | 개시 | BofA Securities | Buy |
| 2024-05-09 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Perspective Therapeutics Inc 주식(CATX)의 최신 뉴스
What technical models suggest about Perspective Therapeutics Inc.’s comeback2025 Volume Leaders & Daily Price Action Insights - Newser
Is Perspective Therapeutics Inc. stock entering bullish territoryPortfolio Return Summary & Weekly Stock Breakout Alerts - Newser
Chart overlay techniques for tracking Perspective Therapeutics Inc.July 2025 Closing Moves & Fast Gain Stock Trading Tips - Newser
Leading vs lagging indicators on Perspective Therapeutics Inc. performanceJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - Newser
How to use a screener to detect Perspective Therapeutics Inc. breakoutsJuly 2025 Summary & Real-Time Volume Analysis Alerts - Newser
Risk vs reward if holding onto Perspective Therapeutics Inc.Trade Performance Summary & Precise Buy Zone Tips - Newser
Perspective Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Reactions & Momentum Based Trading Ideas - Newser
Can volume confirm reversal in Perspective Therapeutics Inc.2025 Major Catalysts & Pattern Based Trade Signal System - Newser
What indicators show strength in Perspective Therapeutics Inc.2025 EndofYear Setup & Safe Capital Investment Plans - Newser
Applying chart zones and confluence areas to Perspective Therapeutics Inc.July 2025 Analyst Calls & Community Verified Swing Trade Signals - Newser
Perspective Therapeutics Announces Chief Financial Officer Changes - MarketScreener
Perspective Therapeutics Names Joel Sendek as CFO - MarketScreener
Perspective Therapeutics Appoints Joel Sendek as CFO - TipRanks
Perspective Therapeutics' Strategic Leadership Shift: How CFO Joel Sendek Could Ignite Financial and Operational Momentum - AInvest
Perspective Therapeutics' Strategic Leadership Move and Its Implications for Biotech Growth - AInvest
Perspective Therapeutics Appoints Biotech Veteran Joel Sendek as Chief Financial Officer - GlobeNewswire
Former Wall Street All-Star Who Raised $2.5B: Perspective Therapeutics Lands Biotech Finance Veteran as CFO - Stock Titan
Smart tools for monitoring Perspective Therapeutics Inc.’s price actionEntry Point & Long-Term Safe Return Strategies - Newser
Aug EndMonth: Can Perspective Therapeutics Inc. deliver alphaJuly 2025 Trade Ideas & High Accuracy Investment Entry Signals - khodrobank.com
Is Perspective Therapeutics Inc. being accumulated by smart moneyEarnings Miss & Short-Term Swing Trade Alerts - خودرو بانک
Building trade automation scripts for Perspective Therapeutics Inc.2025 Breakouts & Breakdowns & Technical Pattern Based Signals - Newser
Will Perspective Therapeutics Inc. outperform the marketEarnings Performance Report & Free Real-Time Market Sentiment Alerts - Newser
Perspective Therapeutics shares fall 1.02% after-hours following appointment of Maya Martinez-Davis to the Board of Directors. - AInvest
How does Perspective Therapeutics Inc. score in quality rankingsWeekly Stock Summary & AI Enhanced Trading Signals - خودرو بانک
Published on: 2025-09-03 09:07:22 - Newser
What institutional flow reveals about Perspective Therapeutics Inc.July 2025 Selloffs & Low Drawdown Investment Strategies - Newser
Perspective Therapeutics Appoints Maya Martinez-Davis to Board - TipRanks
Analyzing drawdowns of Perspective Therapeutics Inc. with statistical tools2025 Year in Review & Real-Time Stock Entry Alerts - Newser
Perspective Therapeutics Appoints Maya Martinez-Davis to Board of Directors. - AInvest
Perspective Therapeutics appoints Maya Martinez-Davis as independent director. - AInvest
Perspective Therapeutics Appoints Maya Martinez-Davis to Board, Boosting Oncology Expertise - AInvest
Perspective Therapeutics Appoints Maya Martinez-Davis to Board of Directors - MarketScreener
GSK US Commercial President Maya Martinez-Davis Joins Perspective Therapeutics' Board of Directors - Stock Titan
Published on: 2025-09-03 04:22:19 - Newser
Custom strategy builders for tracking Perspective Therapeutics Inc.July 2025 Selloffs & Weekly High Return Stock Forecasts - Newser
Analyst Downgrade: How does Perspective Therapeutics Inc. score in quality rankingsWeekly Stock Summary & Free Technical Confirmation Trade Alerts - خودرو بانک
Published on: 2025-09-03 01:26:42 - Newser
ETF Watch: Does Perspective Therapeutics Inc. stock have upside surprise potentialJuly 2025 Technicals & Reliable Price Breakout Alerts - خودرو بانک
Using fundamentals and technicals on Perspective Therapeutics Inc.Quarterly Portfolio Review & Daily Momentum Trading Reports - Newser
Is Perspective Therapeutics Inc. gaining market shareEarnings Risk Report & Daily Profit Focused Stock Screening - خودرو بانک
Perspective Therapeutics Updates on Radiopharmaceutical Advancements - TipRanks
Is a relief rally coming for Perspective Therapeutics Inc. holdersMarket Growth Report & Community Consensus Picks - Newser
Can Perspective Therapeutics Inc. deliver alphaCPI Data & Weekly High Return Forecasts - خودرو بانک
Update Recap: Is Perspective Therapeutics Inc. gaining market share2025 Fundamental Recap & Long-Term Investment Growth Plans - خودرو بانک
Does Perspective Therapeutics Inc. stock reflect fundamentalsWeekly Profit Summary & Daily Growth Stock Tips - خودرو بانک
Perspective Therapeutics Inc. Trading Near Value Zone — Recovery Ahead getLinesFromResByArray error: size == 0 - 강소기업뉴스
Perspective Therapeutics Inc. Volume Confirms Breakout — Analysts Bullish getLinesFromResByArray error: size == 0 - 강소기업뉴스
How institutional ownership impacts Perspective Therapeutics Inc. stockWeekly Investment Summary & Accurate Buy Signal Alerts - Newser
Perspective Therapeutics Inc (CATX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.78%
0.31%
자본화:
|
볼륨(24시간):